Christopher R. Chapple

The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study

Karin S. Coyne, Christopher Sexton, Christine L. Thompson et al. · British Journal of Urology · 2009 · 793 citations · Full text

Medicine, Urology, Clinical Epidemiology +15

Efficacy and Tolerability of Mirabegron, a β3-Adrenoceptor Agonist, in Patients with Overactive Bladder: Results from a Randomised European–Australian Phase 3 Trial

Vik Khullar, G. Amarenco, J.C. Angulo et al. · European Urology · 2012 · 425 citations

Medicine, Pharmacology, Urology +14

OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial

Christopher R. Chapple, Karl‐Dietrich Sievert, Scott MacDiarmid et al. · European Urology · 2013 · 408 citations

Medicine, Pharmacotherapy, Urology +16

Efficacy and Safety of OnabotulinumtoxinA for Idiopathic Overactive Bladder: A Double-Blind, Placebo Controlled, Randomized, Dose Ranging Trial

Roger R. Dmochowski, Christopher R. Chapple, Victor W. Νitti et al. · The Journal of Urology · 2010 · 401 citations

Medicine, Pharmacology, Pharmacotherapy +15

EAU Guidelines on Urinary Incontinence

Joachim W. Thüroff, Paul Abrams, Karl‐Erik Andersson et al. · European Urology · 2010 · 389 citations

Medicine, Surgery, Urology +14